CK2A protein kinase in need of control

Pharmacology and Therapeutics

Volumn 82, Issue 2-3, 1999, Pages 303-313

  Guerra, B ^a   Boldyreff, B ^a   Sarno, S ^b   Cesaro, L ^b   Issinger, O G ^a   Pinna, L A ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

CK2; Inhibitors; Protein kinase; Structure; Substrate recognition

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ADENOSINE TRIPHOSPHATE; CASEIN KINASE II; GUANOSINE TRIPHOSPHATE; HEPARIN; NUCLEOSIDE ANALOG; POLYANION; POLYGLUTAMIC ACID; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; ENZYME INHIBITOR;

CANCER; CELL PROLIFERATION; CONFERENCE PAPER; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME SUBSTRATE; ENZYME SUBUNIT; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; SECOND MESSENGER; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; MOLECULAR GENETICS; PHYSIOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY;

AMINO ACID SEQUENCE; CASEIN KINASE II; CATALYTIC DOMAIN; ENZYME INHIBITORS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PROTEIN-SERINE-THREONINE KINASES; SENSITIVITY AND SPECIFICITY;

EID: 0032587377     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(98)00064-3     Document Type: Conference Paper

References (75)

1. Allende J.E., Allende C.C. Protein kinase CK2. an enzyme with multiple substrates and a puzzling regulation FASEB J. 9:1995;313-323.
2. Bidwai A.P., Reed J.C., Glover C.V.C. Cloning and disruption of CKB1, the gene encoding the 38-kDa β subunit of Saccharomyces cerevisiae casein kinase II (CKII). J. Biol. Chem. 270:1995;10295-10404.
3. Boldyreff B., Issinger O.-G. A-Raf kinase is a new interacting partner of protein kinase CK2 β subunit. FEBS Lett. 403:1997;197-199.
4. Boldyreff B., Meggio F., Pinna L.A., Issinger O.-G. Reconstitution of normal and hyperactivated forms of casein kinase-2 by variably mutated β-subunits. Biochemistry. 32:1993;12672-12677.
5. 2+ adenyl imidodiphosphate and inhibitor peptide PKI(5-24). EMBO J. 12:1993;849-859.
6. Burnett G., Kennedy E.P. The enzymatic phosphorylation of proteins. J. Biol. Chem. 211:1954;969-980.
7. Chen M., Li D., Krebs E.G., Cooper J.A. The casein kinase II β subunit binds to Mos and inhibits Mos activity. Mol. Cell. Biol. 17:1997;1904-1912.
8. De Bondt H.L., Rosenblatt J., Jancarik J., Jones H.D., Morgan D.O., Kim S.-H. Crystal structure of cyclin-dependent kinase 2. Nature. 363:1993;595-602.
9. Dobrowolska G., Muszynska G., Shugar D. Benzimidazole nucleoside analogues as inhibitors of plant (maize seedling) casein kinases. Biochim. Biophys. Acta. 1080:1991;221-226.
10. Egyhazi E., Ossoinak A., Tayip U., Kazimierczuk Z., Shugar D. Specific inhibition of hnRNA synthesis by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. Requirement of a free 3′-hydroxyl group, but not 2′- or 5′-hydroxyls. Biochim. Biophys. Acta. 697:1982;213-220.
11. Gibbs C.S., Zoller M.J. Identification of electrostatic interactions that determine the phosphorylation site specificity of the cAMP-dependent protein kinase. Biochemistry. 30:1991;5329-5334.
12. Grankowski N., Boldyreff B., Issinger O.-G. Isolation and characterization of recombinant human casein kinase II subunits α and β from bacteria. Eur. J. Biochem. 198:1991;25-30.
13. Guerra B., Issinger O.-G. Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis. in press:1999.
14. Guerra B., Niefind K., Pinna L.A., Schomburg D., Issinger O.-G. Expression, purification and crystallization of the catalytic subunit of protein kinase CK2 from Zea mays. Acta Crystallogr. D. 54:1998;143-145.
15. Hagemann C., Kalmes A., Wixler V., Wixler L., Tillmann S., Rapp U.R. The regulatory subunit of protein kinase CK2 is a specific A-Raf activator. FEBS Lett. 403:1997;200-202.
16. Hanks S.K., Quinn A.M. Protein kinase catalytic domain sequence database. identification of conserved features of primary structure and classification of family members Methods Enzymol. 200:1991;38-62.
17. Heriché J.-K., Lebrin F., Rabilloud T., Leroy D., Chambaz E.M., Goldberg Y. Regulation of protein phosphatase 2A by direct interaction with casein kinase 2a. Science. 276:1997;952-955.
18. Hidaka H., Inagaki M., Kawamoto S., Sasaki Y. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry. 23:1984;5036-5041.
19. Issinger O.-G. Casein kinases. pleiotropic mediators of cellular regulation Pharmacol. Ther. 59:1993;1-30.
20. Issinger O.-G., Brockel C., Boldyreff B., Pelton J.T. Characterization of the α and β subunits of casein kinase 2 by far-UV CD spectroscopy. Biochemistry. 31:1992;6098-6103.
21. Jakobi R., Traugh J.A. Characterization of the phosphotransferase domain of casein kinase II by site-directed mutagenesis and expression in Escherichia coli. J. Biol. Chem. 267:1992;23894-23902.
22. Jakobi R., Traugh J.A. Site-directed mutagenesis and structure/function studies of casein kinase II correlate stimulation of activity by the β subunit with changes in conformation and ATP/GTP utilization. Eur. J. Biochem. 230:1995;1111-1117.
23. Jakobi R., Lin W.-J., Traugh J.A. Modes of regulation of casein kinase II. Cell. Mol. Biol. Res. 40:1994;421-429.
24. Jeffrey P.D., Russo A.A., Polyak K., Gibbs E., Hurwitz J., Massagué J., Pavletich N.P. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature. 376:1995;313-320.
25. Johnson L.N., Noble M.E.M., Owen D.J. Active and inactive protein kinases. structural basis for regulation Cell. 85:1996;149-158.
26. Kelliher M.A., Seldin D.C., Leder P. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J. 15:1996;5160-5166.
27. Knighton D.R., Zheng J., Ten Eyck L.F., Ashford V.A., Xuong N.-H., Taylor S.S., Sowadski J.M. Crystal structure of the catalytic subunit of cyclic monophosphate-dependent protein kinase. Science. 253:1991;407-413. a.
28. Knighton D.R., Zheng J., Ten Eyck L.F., Xuong N.-H., Taylor S.S., Sowadski J.M. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic monophosphate-dependent protein kinase. Science. 253:1991;414-420. b.
29. Krehan A., Lorenz P., Plana-Coll M., Pyerin W. Interaction sites between catalytic and regulatory subunits in human protein kinase CK2 holoenzyme as indicated by chemical cross-linking and immunological investigations. Biochemistry. 35:1996;4966-4975.
30. Kuenzel E.A., Mulligan J.A., Sommercorn J., Krebs E.G. Substrate specificity determinants for casein kinase II as deduced from studies with synthetic peptides. J. Biol. Chem. 262:1987;9136-9140.
31. Kusk M., Bendixen C., Dunø M., Westergaard O., Thomsen B. Genetic dissection of intersubunit contacts within human protein kinase CK2. J. Mol. Biol. 253:1995;703-711.
32. Kusk M., Ahmed R.L., Thomsen B., Bendixen C., Issinger O.-G., Boldyreff B. Interactions of protein kinase CK2 β subunit within the holoezyme and with other proteins. Mol. Cell. Biochem. in press:1999.
33. Marin O., Meggio F., Marchiori F., Borin G., Pinna L.A. Site specificity of casein kinase-2 (TS) from rat liver cytosol. A study with model peptide substrates. Eur. J. Biochem. 160:1986;239-244.
34. Marin O., Meggio F., Perich J.W., Pinna L.A. Phosphotyrosine specifies the phosphorylation by protein kinase CK2 of a peptide reproducing the activation loop of the insulin receptor protein tyrosine kinase. Int. J. Biochem. Cell. Biol. 28:1996;999-1005.
35. Marin O., Meggio F., Sarno S., Pinna L.A. Physical dissection of the structural elements responsible for regulatory properties and intersubunit interactions of protein kinase CK2β-subunit. Biochemistry. 36:1997;7192-7198.
36. Meggio F., Pinna L.A. Phosphorylation of phosvitin by casein kinase-2 provides evidence that phosphoserines can replace carboxylic amino acids as specificity determinants. Biochim. Biophys. Acta. 971:1988;227-231.
37. Meggio F., Marchiori F., Borin G., Chessa G., Pinna L.A. Synthetic peptides including acidic clusters as substrates and inhibitors of rat liver casein kinase TS (type-2). J. Biol. Chem. 259:1984;14576-14579.
38. Meggio F., Shugar D., Pinna L.A. Ribofuranosyl-benzimidazole derivatives as inhibitors of casein kinase-2 and casein kinase-1. Eur. J. Biochem. 187:1990;89-94.
39. Meggio F., Perich J.W., Reynolds E.C., Pinna L.A. Phosphotyrosine as specificity determinant from casein kinase-2, a growth related Ser/Thr-specific protein kinase. FEBS Lett. 279:1991;307-309.
40. Meggio F., Boldyreff B., Marin O., Marchiori F., Perich J.W., Issinger O.-G., Pinna L.A. The effect of polylysine on casein-kinase-2 activity is influenced by both the structure of the protein/peptide substrate and the composition of the enzyme. Eur. J. Biochem. 205:1992;939-945. a.
41. Meggio F., Boldyreff B., Marin O., Pinna L.A., Issinger O.-G. Role of the β subunit of casein kinase-2 on the stability and specificity of the recombinant reconstituted holoenzyme. Eur. J. Biochem. 204:1992;293-297. b.
42. Meggio F., Boldyreff B., Issinger O.-G., Pinna L.A. Casein kinase 2 down-regulation and activation by polybasic peptides are mediated by acidic residues in the 55-64 region of the β-subunit. A study with calmodulin as phosphorylatable substrate. Biochemistry. 33:1994;4336-4342. a.
43. Meggio F., Marin O., Pinna L.A. Substrate specificity of protein kinase CK2. Cell. Mol. Biol. Res. 40:1994;401-409. b.
44. Meggio F., Donella-Deana A., Ruzzene M., Brunati A.M., Cesaro L., Guerra B., Meyer T., Mett H., Fabbro D., Furet P., Dobrowolska G., Pinna L.A. Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2. Eur. J. Biochem. 234:1995;317-322.
45. Mestres P., Boldyref B., Ebensperger C., Hameister H., Issinger O.-G. Expression of casein kinase 2 during mouse embryogenesis. Acta Anat. (Basel). 149:1994;13-20.
46. Münstermann U., Fritz G., Seitz G., Yiping L., Schneider H., Issinger O.-G. Casein kinase II is elevated in solid tumours and rapidly non-proliferating tissue. Eur. J. Biochem. 189:1990;251-257.
47. Niefind K., Guerra B., Pinna L.A., Issinger O.-G., Schomburg D. Crystal structure of the catalytic subunit of protein kinase CK2 from Zea mays at 2.1 Å resolution. EMBO J. 17:1998;2451-2462.
48. Nigg E.A., Bauerle P.A., Luhrmann R. Nuclear import-export. in search of signals and mechanisms Cell. 66:1991;15-22.
49. Orlandini M., Semplici F., Ferruzzi R., Meggio F., Pinna L.A., Oliviero S. Protein kinase CK2α′ is induced by serum as a delayed early gene and cooperates with Ha-ras in fibroblast transformation. J. Biol. Chem. 273:1998;21291-21297.
50. Padmanabha R., Chen-Wu J.L.-P., Hanna D.E., Glover C.V.C. Isolation, sequencing and disruption of the yeast CK2A2 gene. casein kinase II is essential for viability in Saccharomyces cerevisiae Mol. Cell. Biol. 10:1990;4089-4099.
51. Perich J.W., Meggio F., Reynolds E.C., Marin O., Pinna L.A. Role of phosphorylated aminoacyl residues in generating atypical consensus sequences which are recognized by casein kinase-2, but not by casein kinase-1. Biochemistry. 31:1992;5893-5897.
52. Pinna, L. A. (1990) Casein kinase II: an "eminence grise" in cellular regulation. Biochim. Biophys. Acta 1954: 267-284.
53. Pinna L.A., Meggio F. Protein kinase CK2 ("casein kinase-2") and its implication in cell division and proliferation. Prog. Cell Cycle Res. 3:1997;77-97.
54. Pistorius K., Seitz G., Remberger K., Issinger O.-G. Differential CKII activities in human colorectal mucosa, adenomas and carcinomas. Onkologie. 14:1991;256-260.
55. Prowald K., Fischer H., Issinger O.-G. Enhanced casein kinase II activity in human tumour cell cultures. FEBS Lett. 176:1984;479-483.
56. Reed J.C., Bidwai A.P., Glover C.V.C. Cloning and disruption of CKB2, the gene encoding the 32-kDa regulatory b′-subunit of Saccharomyces cerevisiae casein kinase II. J. Biol. Chem. 269:1994;18192-18200.
57. Roach P.J. Multisite and hierarchical protein phosphorylation. J. Biol. Chem. 266:1991;14139-14142.
58. Roussou I., Draetta G. The Schizosaccharomyces pombe casein kinase II α and β subunits. evolutionary conservation and positive role of the β subunit Mol. Cell. Biol. 14:1994;576-586.
59. Sarno S., Vaglio P., Meggio F., Issinger O.-G., Pinna L.A. Protein kinase CK2 mutants defective in substrate recognition. J. Biol. Chem. 271:1996;10595-10601.
60. Sarno S., Vaglio P., Marin O., Issinger O.-G., Ruffato K., Pinna L.A. Mutational analysis of residues implicated in the interaction between protein kinase CK2 and peptide substrates. Biochemistry. 36:1997;11717-11724. a.
61. Sarno S., Vaglio P., Marin O., Meggio F., Issinger O.-G., Pinna L.A. Basic residues in the 74-83 and 191-198 segments of protein kinase CK2 catalytic subunit are implicated in negative but not positive regulation by the β-subunit. Eur. J. Biochem. 248:1997;290-295. b.
62. Sarno S., Vaglio P., Cesaro L., Marin O., And Pinna L.A. A multifunctional network of basic residues confers unique properties to protein kinase CK2. Mol. Cell. Biochem. in press:1999.
63. Schneider H.R., Reichert G., Issinger O.-G. Enhanced casein kinase II activity during mouse embryogenesis. Eur. J. Biochem. 161:1986;733-738.
64. Sehgal P.B., Tamm I. Halogenated benzimidazole ribosides, novel inhibitors of RNA synthesis. Biochem. Pharmacol. 27:1978;2475-2485.
65. Seldin D.C., Leder P. Casein kinase IIa transgene-induced murine lymphoma. relation to theileriosis in cattle Science. 267:1995;894-897.
66. Stalter G., Siemer S., Becht E., Ziegler M., Remberger K., Issinger O.-G. Asymmetric expression of protein kinase CK2 subunits in human kidney tumors. Biochem. Biophys. Res. Commun. 202:1994;141-147.
67. Szyszka R., Grankowski N., Felczak K., Shugar D. Halogenated benzimidazoles as selective inhibitors of protein kinases CK I and CK II from Saccharomyces cerevisiae and other sources. Biochem. Biophys. Res. Commun. 208:1995;418-424.
68. Taylor S.S., Radzio-Andzelm E. Three protein kinase structures define a common motif. Structure. 2:1994;345-355.
69. Taylor S.S., Radzio-Anzelm E., Hunter T. How do protein kinases discriminate between serine/threonine and tyrosine? Structural insights from the insulin receptor protein-tyrosine kinase. FASEB J. 9:1995;1255-1266.
70. Tuazon P.T., Traugh J.A. Casein kinase I and II - multipotential protein kinases. structure, function and regulation Adv. Second Messenger Phosphoprotein Res. 23:1991;123-163.
71. Vaglio P., Sarno S., Marin O., Meggio F., Boldyreff B., Issinger O.-G., Pinna L.A. Mapping the residues of protein kinase CK2 α subunit responsible for responsiveness to polyanionic inhibitors. FEBS Lett. 380:1996;25-28.
72. Wilson L.K., Dhillon N., Martin G.S. Casein kinase II catalyzes tyrosine phosphorylation of the yeast nucleolar immunophilin Fpr3. J. Biol. Chem. 272:1997;12961-12967.
73. Xu, X. and Seldin, D. C. (1998) Gene targeting of the α′ catalytic subunit of protein kinase CK2 reveals an essential role in spermatogenesis. In: Abstracts of the 10th International Conference on Second Messengers and Phosphoproteins, Jerusalem, November 8-13, 1998, p. 6.
74. Zandomeni R., Zandomeni M.C., Shugar D., Weinmann R. Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole of specific RNA polymerase II transcription. J. Biol. Chem. 261:1986;3414-3419.
75. Zheng J., Knighton D.R., Xuong N.-H., Taylor S.S., Sowadski J.M., Ten Eyck L.F. Crystal structures of the myristylated catalytic subunit of cAMP-dependent protein kinase reveal open and closed conformations. Protein Sci. 2:1993;1559-1573.